Prostate biopsy
Prostate biopsy is a medical procedure with 38 clinical trials. Currently 12 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
80.0%
12 of 15 finished
20.0%
3 ended early
12
trials recruiting
38
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)
Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer
Clinical Trials (38)
The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).
Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)
Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer
Is it Feasible to Use Data Obtained Through a Three-Dimensional Reconstructed Image to Assist in Prostate Targeted Biopsy?
Assessment of Prostate MRI Before Prostate Biopsies
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
The BARCODE 1 Pilot Study
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
A Study of Changes to Prostate Procedures
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Evaluation of the Effect on Pain of Attentional Diversion Associated with Hypnotic Induction by Virtual Reality (VRH) in Perioperative Prostate Biopsies Under Local Anesthesia:
Early Staged Consent Before Prostate Biopsy
Optimizing the Number of Systematic COres During a MRI Target Biopsy
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 38